Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$5,200,000.00
Nov 1, 2021
For-profit organization
COVID-19 Vaccine: Phase 2 clinical trial of DNA-based vaccine Covigenix VAX-001
981653
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In this project, Entos will advance the VAX-001 vaccine candidate through Phase 2 clinical trials to establish its safety and immunogenicity in healthy adults.
$4,000,000.00
Oct 29, 2021
Not-for-profit organization or charity
Multi-country COVID-19 Emergency Response
7434864 P010733001
This project is a 12-month Canadian Red Cross initiative that aims to decrease coronavirus (COVID-19) related mortality and morbidity of populations. The project focuses on those experiencing marginalization and/or vulnerability in six conflict-impacted countries in Africa (Central African Republic, Somalia and South Sudan), the Americas (Haiti), Asia (Bangladesh) and the Middle East (Syria). This is achieved by a series of activities designed to increase equitable coverage of public health and health care services for people infected with COVID-19 and improve community response to and recovery from COVID-19 with specific measures for women, girls and those experiencing marginalization or vulnerability. The project expects to reach a total of 1,168,400 people.
$1,047,620.00
Oct 27, 2021
Not-for-profit organization or charity
Support to Health Human Resources in Saskatchewan (CRC)
22333
Following a request for federal assistance from the Province of Saskatchewan, the Canadian Red Cross will support the Federal Government's response by providing surge Health Human Resources to the Saskatchewan Health Authority (SHA).
$41,560.00
Oct 26, 2021
For-profit organization
Pilot Study to Assess if a novel DNA and/or RNAi ISA vaccine can be administered through oral route to fish and a safety study of a plant-based feed stabilizer in Atlantic Salmon (Salmo salar).
977101
We have developed a unique oral vaccination platform based on this technology which could be used for prevention of ISAV infection in farmed salmon.
$536,614.00
Oct 19, 2021
Not-for-profit organization or charity
Vaccination Support in Nova Scotia
22246
The Canadian Red Cross will support the federal response by supporting the Province’s vaccine roll-out plan. Specifically, clinical and non-clinical support will be provided to a vaccination clinic in Halifax, Nova Scotia from June 25, 2021 to July 16, 2021 to increase capacity to immunize as many people as possible with both doses of the COVID-19 vaccine in order to maximize protection against the delta variant. On-site services will include immunizers, greeting, site navigation, spot sanitization, safety and wellbeing, and post-vaccine observation.
$77,176.00
Oct 16, 2021
For-profit organization
Development of tolerogenic lipid nanoparticle (LNP) formulation containing messenger ribonucleic acid (mRNA)
982040
Development of lipid nanoparticles (LNP) encasing mRNA for vaccines.
$43,537.00
Oct 4, 2021
International (non-government)
Contribution to Action Aid
CFLI-2021-DELHI-0002
Enhancing the preparedness for and response to the COVID-19 of the vulnerable communities in Bihar and Jharkhand states of India through awareness campaigns, capacity building trainings, medical camps, vaccination drives and regular interface with local authorities.
$200,000.00
Oct 1, 2021
Individual or sole proprietorship
Operating Grant: COVID-19 Vaccine Confidence
162698
The specific objectives of this funding opportunity are to advance knowledge and strategies on how to increase vaccine confidence in populations experiencing conditions of marginalization, Indigenous Peoples and/or populations who have historically been under-vaccinated, including how to address structural, contextual, intersectional and historical barriers to vaccination by:
1) Addressing knowledge gaps related to understanding the causes and contributing factors to lower vaccination confidence associated with COVID-19, and provide communities, healthcare providers, and public health and health system leaders with actionable evidence to improve vaccine confidence and uptake in clinical and/or community contexts; and
2) Designing, implementing and/or evaluating promising interventions to increase vaccine confidence, including a focus on which approaches are most effective, in which populations and contexts, and why (implementation science approach).
$150,005.00
Oct 1, 2021
Individual or sole proprietorship
Operating Grant: COVID-19 Vaccine Confidence
163073
The specific objectives of this funding opportunity are to advance knowledge and strategies on how to increase vaccine confidence in populations experiencing conditions of marginalization, Indigenous Peoples and/or populations who have historically been under-vaccinated, including how to address structural, contextual, intersectional and historical barriers to vaccination by:
1) Addressing knowledge gaps related to understanding the causes and contributing factors to lower vaccination confidence associated with COVID-19, and provide communities, healthcare providers, and public health and health system leaders with actionable evidence to improve vaccine confidence and uptake in clinical and/or community contexts; and
2) Designing, implementing and/or evaluating promising interventions to increase vaccine confidence, including a focus on which approaches are most effective, in which populations and contexts, and why (implementation science approach).
$100,000.00
Oct 1, 2021
Individual or sole proprietorship
Operating Grant: COVID-19 Vaccine Confidence
162695
The specific objectives of this funding opportunity are to advance knowledge and strategies on how to increase vaccine confidence in populations experiencing conditions of marginalization, Indigenous Peoples and/or populations who have historically been under-vaccinated, including how to address structural, contextual, intersectional and historical barriers to vaccination by:
1) Addressing knowledge gaps related to understanding the causes and contributing factors to lower vaccination confidence associated with COVID-19, and provide communities, healthcare providers, and public health and health system leaders with actionable evidence to improve vaccine confidence and uptake in clinical and/or community contexts; and
2) Designing, implementing and/or evaluating promising interventions to increase vaccine confidence, including a focus on which approaches are most effective, in which populations and contexts, and why (implementation science approach).